Hydroxychloroquine: Unpacking the Controversy on American Medicine Today
If the people will take hydroxychloroquine as a prophylactic medicine, they will not get sick. It's already proved in vitro that works against the coronavirus. The problem is if we don't try seriously, then we are not going to have a solution and we will continue with these up and downs of people dying and getting infected.
Ever wondered why hydroxychloroquine is such a hot topic in healthcare? In this episode of 'American Medicine Today', hosts Kimberly Bermel, Ethan Youker, and Jeff Wagstaff team up with renowned orthopedic surgeon Dr. Alfred Bonati to tackle this very question. The conversation dives into the buzz around hydroxychloroquine's role in COVID-19 treatment and the ongoing debates that surround it. Dr.
Bonati doesn't hold back as he expresses his frustration over the lack of serious studies on hydroxychloroquine, despite its proven effectiveness against the coronavirus in lab settings. He passionately argues for its use as a preventative measure in the early stages of the disease and stresses the importance of personal healthcare advocacy. The episode also sheds light on the influence of big pharma, urging listeners to take charge of their own health decisions.
If you're curious about the latest in healthcare innovations and the politics that shape them, this episode is a must-listen. It’s a blend of serious discussion and engaging insights that will leave you better informed about this controversial topic.